{"organizations": [], "uuid": "ef88bc96305e3744d8602360c0a7c79f379b4d59", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-spectrum-pharmaceuticals-enters-in/brief-spectrum-pharmaceuticals-enters-into-a-next-generation-sequencing-companion-diagnostic-partnership-with-thermo-fisher-scientific-idUSFWN1S806Z", "country": "US", "domain_rank": 408, "title": "BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-01T14:35:00.000+03:00", "replies_count": 0, "uuid": "ef88bc96305e3744d8602360c0a7c79f379b4d59"}, "author": "", "url": "https://www.reuters.com/article/brief-spectrum-pharmaceuticals-enters-in/brief-spectrum-pharmaceuticals-enters-into-a-next-generation-sequencing-companion-diagnostic-partnership-with-thermo-fisher-scientific-idUSFWN1S806Z", "ord_in_thread": 0, "title": "BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-spectrum pharmaceuticals", "sentiment": "negative"}, {"name": "spectrum pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "sequencing companion diagnostic partnership with thermo fisher scientific reuters staff", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 1, 2018 / 11:36 AM / Updated 5 minutes ago BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific Reuters Staff\nMay 1 (Reuters) - Spectrum Pharmaceuticals Inc:\n* SPECTRUM PHARMACEUTICALS ENTERS INTO A NEXT-GENERATION SEQUENCING COMPANION DIAGNOSTIC PARTNERSHIP WITH THERMO FISHER SCIENTIFIC\n* SPECTRUM PHARMACEUTICALS INC - ENTERED INTO AN AGREEMENT WITH THERMO FISHER SCIENTIFIC\n* SPECTRUM PHARMACEUTICALS - AGREEMENT TO LEVERAGE ONCOMINE DX TARGET TEST AS COMPANION DIAGNOSTIC FOR SPECTRUMâ€™S NOVEL PAN-HER INHIBITOR POZIOTINIB Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-05-01T14:35:00.000+03:00", "crawled": "2018-05-01T14:56:57.001+03:00", "highlightTitle": ""}